Cortexyme
$1.95
59
+$0.05+2.63% Friday 22:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-1.558
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-156.49MNet Income
Analyst Ratings
0Average Price Target
The highest estimate is 0.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CRTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sangamo Therapeutics
SGMO
Mkt Cap108.54M
CRISPR Therapeutics
CRSP
Mkt Cap5.57B
Editas Medicine
EDIT
Mkt Cap341.57M
Intellia Therapeutics
NTLA
Mkt Cap1.77B
Voyager Therapeutics
VYGR
Mkt Cap246.15M
Protagonist Therapeutics
PTGX
Mkt Cap6.76B
Fate Therapeutics
FATE
Mkt Cap161.61M
Regenxbio
RGNX
Mkt Cap489.85M
About
Biotechnology
Health Technology
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Show more...
CEO
Employees
37
Country
United States
ISIN
US22053A1079
Listings
0 Comments
Share your thoughts
FAQ
What is Cortexyme stock price today?▼
The current price of CRTX is $1.95 USD — it has increased by +2.63% in the past 24 hours. Watch Cortexyme stock price performance more closely on the chart.
What is Cortexyme stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cortexyme stocks are traded under the ticker CRTX.
What were Cortexyme earnings last quarter?▼
CRTX earnings for the last quarter are 0 USD per share, whereas the estimation was -0.29 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cortexyme revenue for the last year?▼
Cortexyme revenue for the last year amounts to 0 USD.
What is Cortexyme net income for the last year?▼
CRTX net income for the last year is -156.49M USD.
How many employees does Cortexyme have?▼
As of April 21, 2026, the company has 37 employees.
In which sector is Cortexyme located?▼
Cortexyme operates in the Technology sector.
When did Cortexyme complete a stock split?▼
Cortexyme has not had any recent stock splits.